KDR and cancer: In vitro cytotoxicity of the synthesised compounds against MCF-7 and HepG2 cell lines, their VEGFR-2 inhibitory activities on cancer HepG2 cell line, and cytotoxicity for compounds 27a and 30f against normal HepG2cell line.